Dose-response effects of 32P radioactive stents in an atherosclerotic porcine coronary model

Circulation. 1999 Oct 5;100(14):1548-54. doi: 10.1161/01.cir.100.14.1548.

Abstract

Background: Experimental studies have demonstrated that 32P radioactive stents reduce neointimal formation at 28 days in porcine iliac and coronary arteries. Our objective was to determine the long-term dose-response effects of 1.0- to 12.0-microCi 32P radioactive stents in a porcine atherosclerotic coronary model.

Methods and results: Control (n=19) and 1.0- to 12.0-microCi 32P radioactive (n=43) stents (total, n=62) were implanted in the coronary arteries of 31 miniature swine at 28 days after creation of a fibrocellular plaque by overstretch balloon injury and cholesterol feeding. Angiography and histomorphometry were performed at 6 months. Stent thrombosis occurred in 3 radioactive (7.7%) and no control stents (P=0.54). On histology, the mean neointimal area and the percent in-stent stenosis correlated positively with increasing stent activity (r=0.64, P<0.001). The mean neointimal area (mm2) for the stents with >/=3.0 microCi 32P (3.57+/-1.21) was significantly greater than that for the nonradioactive stents (1.78+/-0.68, P<0.0001). The neointima of the stents with >/=3.0 microCi 32P was composed of smooth muscle cells, matrix proteoglycans, calcification, foam cells, and cholesterol clefts.

Conclusions: Continuous low-dose-rate irradiation delivered by high-activity (32)P radioactive stents promotes the formation of an "atheromatous" neointima after 6 months in this experimental model. These data may be useful for predicting late tissue responses to radioactive stents in human coronary arteries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Coronary Angiography
  • Coronary Artery Disease / therapy*
  • Coronary Thrombosis / etiology
  • Coronary Vessels / pathology
  • Coronary Vessels / radiation effects*
  • Dose-Response Relationship, Radiation
  • Muscle, Smooth, Vascular / diagnostic imaging*
  • Muscle, Smooth, Vascular / pathology
  • Phosphorus Radioisotopes / therapeutic use*
  • Stents* / adverse effects
  • Swine
  • Swine, Miniature

Substances

  • Phosphorus Radioisotopes